Loading data for ENSC — first visit, this takes a few seconds.
Ensysce Biosciences Inc. (ENSC)
NasdaqCM: ENSC
· Real-Time Price · USD
0.39
+0.00 (0.00%)
At close: Aug 19, 2026, 8:00 PM
0.37
-4.64%
After-hours: 7:58 PM
Ensysce Biosciences Inc. (ENSC) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | 0.27 |
| Market Cap | 7.55M |
| Revenue (ttm) | 4.5M |
| Net Income (ttm) | -12.62M |
| Beta | n/a |
| EPS (ttm) | -2.56 |
| PE Ratio (ttm) | n/a |
| Forward PE | -7.76 |
| P/B (ttm) | -8.08 |
| P/S (ttm) | 1.68 |
| Earnings Date | Aug 14, 2025 |
| Ask | 0.48 |
| Volume | 1,491,700 |
| Avg. Volume (20D) | 14,847,037 |
| Open | 0.37 |
| Previous Close | 0.39 |
| Day's Range | 0.37 - 0.39 |
| 52-Week Range | 0.23 - 2.75 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ENSC
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug t...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 14, 2018
Employees 8
Stock Exchange NasdaqCM
Ticker Symbol ENSC
Website https://www.ensysce.com
Financial Performance
In 2025, Ensysce Biosciences's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -10.18M, an increase of 27.4%.
Financial StatementsEarnings Surprise
Ensysce Biosciences has released their quarterly earnings on Aug 13, 2026:
Ensysce Biosciences Inc. is scheduled to release its earnings on Aug 14, 2025, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
5 months ago · Associated Press Finance
BC-Most Active StocksElong Power Holding Ltd. 27,481,598 0.1358